Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth


» Details

Guru Trades

Q3 2014

IBB Guru Trades in Q3 2014

George Soros 150,000 sh (unchged)
» More
Q4 2014

IBB Guru Trades in Q4 2014

John Keeley 905 sh (New)
» More
Q1 2015

IBB Guru Trades in Q1 2015

John Keeley 905 sh (unchged)
» More
Q2 2015

IBB Guru Trades in Q2 2015

George Soros 2,400 sh (New)
John Keeley 905 sh (unchged)
» More
» Details

Insider Trades

Latest Guru Trades with IBB

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )



Valuation & Return


Business Description

Industry: »
Compare:0 » details
» More Articles for IBB


Articles On GuruFocus.com
Vista Partners Initiates Coverage on Immune Pharmaceuticals Inc. (NasdaqCM: IMNP); $6.00 Price Targe Jul 23 2015 
Shen Jun 24 2015 
Shen Jun 24 2015 
Investment Strategies for the Bullish Biotech Sector Jun 01 2015 

More From Other Websites
Exelixis, Medicines Company Trade above 100-Day Moving Averages Oct 12 2015
Dyax Rises 21%, IBB Falls 2.2% for Week Ended October 9 Oct 12 2015
Stocks close higher; Nasdaq tops 50-day moving average Oct 12 2015
Mining earnings gold Oct 12 2015
Alkermes’s Aristada and Its FDA Approval for Schizophrenia Oct 12 2015
Finding faith in Pharma Oct 12 2015
Dyax Outperformed the Pharmaceutical Subgroup with a 6.1% Rise Oct 12 2015
Jim Cramer -- Regeneron's Rally Is Going to Boost Biotechs Oct 12 2015
Zacks Investment Ideas feature highlights: iShares Nasdaq Biotechnology, SPDR S&P Biotech ETF,... Oct 12 2015
This Could Be the Next Billion Dollar Biotech Oct 11 2015
Christian Tharp Talks The Biotech Industry And The IBB Oct 10 2015
Momentum ETFs: A Good Idea in Theory, Not Reality Oct 10 2015
Stocks close higher ahead of earnings; S&P posts best week of 2015 Oct 09 2015
Dysfunction Junction: DC & your dollar Oct 09 2015
Volatility Rises: How Should You Position Your Portfolio? Oct 09 2015
4 Stocks, 4 trades: Gap, Netflix, and more Oct 09 2015
IMMU and ACRX Outperform in the Biotech Downdraft Oct 09 2015
IBB Underperform in the Mid-Cap Space on October 6 Oct 09 2015
Simply the Single Best Biotech in the World Oct 09 2015
Gilead Sciences: Another Volatile Week For Hep-C Oct 09 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)